Busca avançada

Compartilhar

English Português

Início Os mais lidos

Hematology, Transfusion and Cell Therapy

Hematology, Transfusion and Cell Therapy

ISSN: 2531-1379

Hematology, Transfusion and Cell Therapy é uma publicação científica trimestral da Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular (ABHH), Associazione Italo-Brasiliana di Ematologia (AIBE), Eurasian Hematology Oncology Group (EHOG) e Sociedade Brasileira de Oncologia Pediátrica (SOBOPE).

A Hematology, Transfusion and Cell Therapy publica artigos originais, artigos de revisão e relatos de caso relacionados com várias temáticas da área de hematologia e hemoterapia. Até 2017, a revista foi publicada sob o título Revista Brasileira de Hematologia e Hemoterapia.

ISSN print: 2531-1379
ISSN online: 2531-1387

Publicado por Elsevier Editora Ltda, Rio de Janeiro, Brasil.

Ver mais

Indexada em:

Scopus, Medline, Directory of Open Access Journals (DOAJ), PubMed Central (PMC), Emerging Sources Citation Index (ESCI), SCImago Journal Rank (SJR), SNIP

Ver mais

Siga-nos:

Fator de impacto

O fator de impacto mede o número médio de citações recebidas em um ano por trabalhos publicados na revista durante os dois anos anteriores.

© Clarivate Analytics, Journal Citation Reports 2025

Ver mais

Fator de impacto 2024

1.6

Citescore

O CiteScore mede as citações médias recebidas por documento publicado. Mais informação

Ver mais

Citescore 2024

2.0

SJR

SJR é uma métrica de prestígio baseada na idéia de que todas as citações não são iguais. SJR utiliza um algoritmo similar ao page rank do Google; é uma medida quantitativa e qualitativa ao impacto de uma publicação.

Ver mais

SJR 2024

0.360

SNIP

SNIP permite comparar o impacto de revistas de diferentes campos temáticos, corrigindo as diferenças na probabilidade de ser citado que existe entre revistas de distintas matérias.

Ver mais

SNIP 2024

0.754

Primera decisão em

The median number of days it takes for an article to go from submission to first editorial decision.

Ver mais

Primera decisão em

33 dias

Ver mais metricas

Informação da revista

Os mais lidos

O arquivo inteiro

Vol. 48. Núm. 2

4086

Lymphoma-associated hemophagocytic lymphohistiocytosis

Thomás de Souza Patto Marcondes, Carlos Sérgio Chiattone, Rafael Dezen Gaiolla

Hematol Transfus Cell Ther. 2026;48:106087

4086

Acesso de texto completo

Compartilhar

1380

Evaluation of the effects of fucoidan extracted from sargassum angustifolium on coagulation factors and biochemical parameters in male Wistar rats

Asma Dehghani, Ameneh Khoshvaghti, Narges Obeidi

Hematol Transfus Cell Ther. 2026;48:106073

1380

Acesso de texto completo

Compartilhar

1333

In patients with suspected thrombotic thrombocytopenic purpura, what is the optimal time to therapeutic plasma exchange?

Alexandre Soares Ferreira Junior, Kate Sanborn, Morgana Pinheiro Maux Lessa, Alexander Gordee, Maragatha Kuchibhatla, Allison O. Taylor, Matthew S. Karafin, Oluwatoyosi A. Onwuemene

Hematol Transfus Cell Ther. 2026;48:106223

1333

Acesso de texto completo

Compartilhar

1312

Outcomes after bone marrow versus peripheral blood haploidentical hematopoietic cell transplantation using post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis

Muhammad Kashif Amin, Moazzam Shahzad, Abat Khan, Valiko Begiashvili, Ushna Khan, Matthew McGuirk, Shaun DeJarnette, Sibgha Gull Chaudhary, ... Muhammad Umair Mushtaq

Hematol Transfus Cell Ther. 2026;48:106222

1312

Acesso de texto completo

Compartilhar

1252

Drug development for sickle cell disease: repeated setbacks, yet there remains an optimistic outlook for future breakthroughs

Rodolfo Cançado, Fernando Ferreira Costa

Hematol Transfus Cell Ther. 2026;48:106251

1252

Acesso de texto completo

Compartilhar

1206

Identification of an in-frame insertion in ACKR1 in five individuals from Agri community, India

Shaikh Roshan, Solanki Prakash, Ghosh Kanjaksha, Gorakshakar Ajit

Hematol Transfus Cell Ther. 2026;48:106075

1206

Acesso de texto completo

Compartilhar

1084

Changes in the microbiota following allogeneic hematopoietic stem cell transplantation: A potential bioguide for clinical outcome?

Ekin Ece Gurer-Kluge, Fatma Savran Oguz, Zerrin Aktas, Sevgi Kalayoglu Besisik, Ugur Sezerman, Oral Oncul, Zafer Gulbas

Hematol Transfus Cell Ther. 2026;48:106074

1084

Acesso de texto completo

Compartilhar

1055

Integrating comprehensive care in the management of sickle cell disease patients in Nigeria

Efobi Chilota Chibuife, Nri-Ezedi Chisom Adaobi, Chilaka Ugochinyere Jenny, Okoye Helen Chioma, Anigbogu Ikechukwu Okwudili, Okwummuo Emeka Paul, Ogundeji Sunday Peter, Eze Onyinye Ezinne

Hematol Transfus Cell Ther. 2026;48:106091

1055

Acesso de texto completo

Compartilhar

1049

Assessment of the neutrophil-to-lymphocyte ratio as a prognostic marker in patients with newly diagnosed diffuse large B-cell lymphoma: A Colombian Cohort Study

Paula María Sánchez, Juan Felipe Combariza-Vallejo

Hematol Transfus Cell Ther. 2026;48:106237

1049

Acesso de texto completo

Compartilhar

996

Obstetrical use of intravenous immunoglobulin: A single-centre retrospective study

Roy Khalife, Bonnie Niu, Iris Perelman, Darine El-Chaâr, Dean Fergusson, Alan Karovitch, Johnathan Mack, Melanie Tokessy, ... Alan Tinmouth

Hematol Transfus Cell Ther. 2026;48:106225

996

Acesso de texto completo

Compartilhar

975

Cold-stored platelets: A systematic review of recovery in healthy adults and chest drain output in cardiothoracic surgery patients

Caleb Keane, Heba Sharif, Denise Jackson

Hematol Transfus Cell Ther. 2026;48:106226

975

Acesso de texto completo

Compartilhar

951

Hereditary thrombocytopenias: the challenge of increasing frequency and differential diagnosis

Rafiye Çiftçiler

Hematol Transfus Cell Ther. 2026;48:106076

951

Acesso de texto completo

Compartilhar

843

First report of perioperative iptacopan interruption in paroxysmal nocturnal hemoglobinuria without breakthrough hemolysis

Katsuhiro Tokuda, Tatsuki Morioka, Shoya Arai, Takuji Matsuo, Kensuke Matsumoto, Ryosuke Shirasaki, Jun Ooi, Haruko Tashiro

Hematol Transfus Cell Ther. 2026;48:106235

843

Acesso de texto completo

Compartilhar

833

Platelet transfusion in end-of-life adult care

Diana Cibele, Fernanda Trigo, Miguel Barbosa, Jorge Almeida, José Artur Paiva, Edna Gonçalves, João Brito, José Teixeira, Fernando Araújo

Hematol Transfus Cell Ther. 2026;48:106228

833

Acesso de texto completo

Compartilhar

806

Efficacy and safety analysis of the use of ibrutinib associated with rituximab for the first-line treatment of patients with chronic lymphocytic leukaemia

Aline do Nascimento, Daniel da Silva Pereira Curado, Thais Montezuma, Wallace Breno Barbosa, Juliana Machado-Rugolo, Mariana Millan Fachi

Hematol Transfus Cell Ther. 2026;48:106234

806

Acesso de texto completo

Compartilhar

806

Mechanistic insights into the antiproliferative effect of the redox-active iron chelator Dp44mT on multiple myeloma cell lines

Aarti Sharma, Latha Pathangey, Sinto Sebastian Chirackal, Kiran K. Mangalaparthi, Akhilesh Pandey, Rafael Fonseca, Sundararaman Swaminathan

Hematol Transfus Cell Ther. 2026;48:106233

806

Acesso de texto completo

Compartilhar

727

Association of the ABCB1 gene polymorphism C3435T (rs1045642) with acute myeloid leukemia: A genetic study

Roh Ullah, Nazish Mazari, Ghulam Mustafa, Aisha Hameed, Shagufta Khaliq, Ali Amar, Faiz Ul Haq, Asif Haleem Khan, Asif Naveed

Hematol Transfus Cell Ther. 2026;48:106239

727

Acesso de texto completo

Compartilhar

716

Acute fibrinous and organizing pneumonia after bone marrow transplantation, an underrecognized, severe condition

Anita Cassoli Cortez, Maria Cristina Nunez Seiwald, Ana Rita Brito Medeiros da Fonseca, Aliana Meneses Ferreira, Gabriella Pogorzelski, Leonardo de Abreu Testagrossa, Yana Novis, André Nathan Costa

Hematol Transfus Cell Ther. 2026;48:106238

716

Acesso de texto completo

Compartilhar

661

Mesenchymal stromal cells secretory pattern contributes to oncoinflammatory bone marrow microenvironment in polycythemia vera

Juçara Gastaldi Cominal, Maira da Costa Cacemiro, Giovana Michelassi Berbel, Rifkath Marie Laurance Rahimy, Gisele Vieira Rocha, Dalila Lucíola Zanette, Maria Carolina Oliveira, Lorena Lobo de Figueiredo-Pontes, ... Fabíola Attié de Castro

Hematol Transfus Cell Ther. 2026;48:106224

661

Acesso de texto completo

Compartilhar

660

Hypoxic conditions confer chemoresistance to crizotinib but not to imatinib in chronic myeloid leukemia cells

Lena Avinery, Danielle Regev, Hazem Khamaisi, Jacob Gopas, Jamal Mahajna

Hematol Transfus Cell Ther. 2026;48:106240

660

Acesso de texto completo

Compartilhar

Idiomas

Hematology, Transfusion and Cell Therapy